van Eeden, Charmaine.Wibmer, Constantinos Kurt.Scheepers, Cathrine.Richardson, Simone I.Nonyane, Molati.Lambson, Bronwen Elizabeth.Mkhize, Nonhlanhla N.Vijayakumar, Balakrishnan.Sheng, Zizhang.Stanfield-Oakley, Sherry.Bhiman, Jinal N.Bekker, Valerie.Hermanus, Tandile.Mabvakure, Batsirai.Ismail, Arshad.Moody, Michael Anthony.Wiehe, Kevin.Garrett, Nigel Joel.Abdool Karim, Salim Safurdeen.Dirr, Heini.Fernandes, Manuel A.Sayed, Yasien.Shapiro, Lawrence.Ferrari, Guido.Haynes, Barton F.Moore, Penelope L.Morris, Lynn.2019-12-152019-12-1520182018van Eeden, C., Wibmer, C.K., Scheepers, C., Richardson, S.I., Nonyane, M., Lambson, B., Mkhize, N.N., Vijayakumar, B., Sheng, Z., Stanfield-Oakley, S., Bhiman, J.N., Bekker, V., Hermanus, T., Mabvakure, B., Ismail, A., Moody, M.A., Wiehe, K., Garrett, N., Abdool Karim, S.S., Dirr, H., Fernandes, M.A., Sayed, Y., Shapiro, L., Ferrari, G., Haynes, B.F., Moore, P.L. and Morris, L. 2018. V2-directed vaccine-like antibodies from HIV-1 infection identify an additional K169-binding light chain motif with broad ADCC activity. Cell Reports 25(11), 3123-3135.http://dx.doi.org/10.1016/j.celrep.2018.11.058https://researchspace.ukzn.ac.za/handle/10413/16654CAPRISA, 2018.Abstract available in pdf.enADCC.CAP228.CH58.ED motif.HIV.K169.RV144 vaccine response.V2 antibodies.V2 structure.Antibody evolution.Article